bullish
China A-Share Strategy: What Are Mutual Funds Buying in 1Q? Tech and Pharma
267 Views26 Apr 2020 05:09
Chinese fund managers have added more tech and pharma stocks than any other sectors in their portfolios in 1Q this year, according to the fund...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Roger Xie
China and US Equity Analyst
- China Equity Strategy: US Holding Foreign Companies Accountable Act -- A Lengthy Process to Watch24 May 2020
- China A-Share Strategy: R/QFII Quota Removal to Offer More Attractive Channel to Invest In China17 May 2020
- China A-Share Strategy: Further Reform at Chinese-Style NASDAQ Exchange (ChiNext)03 May 2020
- China A-Share Strategy: What Are Mutual Funds Buying in 1Q? Tech and Pharma26 Apr 2020
- China A-Share Strategy: Unexciting 1Q Earnings And Focus Shifted to Economy Reopen19 Apr 2020
- China A-Share Strategy: New Loan Top Record-High $1 Trillion in 1Q as Business Gradually Reopened13 Apr 2020
x